Orasi Medical
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Orasi Medical sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,751 sponsors by registered trial count).
Orasi Medical: 3 sponsored US clinical trials, none currently recruiting.
Orasi Medical sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Healthy, with 1 trials.
Upper-quartile sponsor footprint
Orasi Medical sits in the upper quartile of the sponsor corpus (#3,661 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Acute Effect of Three Neuroactive Drugs Measured by Magnetoencephalography (MEG), Electroencephalography (EEG) and the Synchronous Neural Interaction Test
NCT00972985
Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
NCT00973518
Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test
NCT00666445
Therapeutic Areas
How the Orasi Medical archive is shaped
3 indexed studies, none listed as recruiting (0% open); 3 completed (100%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Healthy (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.